Voglibose

伏格列波糖

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameVoglibose
Drug Alias Namevoglibosum伏利波糖伏格波糖voglibosevoglibosa +[10] 
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionMaltase-glucoamylase inhibitors
TargetsMaltase-glucoamylase
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaDiabetes Mellitus
Original Approved Country/TerritoryJapan
Original Approved Date1994/07/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEverest Medicines (China) Co LtdEverest Medicines LtdTakeda Pharmaceutical Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeA10BF03
Related LinksWikipediaDrugBankKEGG